BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 30138632)

  • 21. CNN-BLPred: a Convolutional neural network based predictor for β-Lactamases (BL) and their classes.
    White C; Ismail HD; Saigo H; Kc DB
    BMC Bioinformatics; 2017 Dec; 18(Suppl 16):577. PubMed ID: 29297322
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of a new allelic variant of the Acinetobacter baumannii cephalosporinase, ADC-7 beta-lactamase: defining a unique family of class C enzymes.
    Hujer KM; Hamza NS; Hujer AM; Perez F; Helfand MS; Bethel CR; Thomson JM; Anderson VE; Barlow M; Rice LB; Tenover FC; Bonomo RA
    Antimicrob Agents Chemother; 2005 Jul; 49(7):2941-8. PubMed ID: 15980372
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dual-layer wavelet SVM for predicting protein structural class via the general form of Chou's pseudo amino acid composition.
    Chen C; Shen ZB; Zou XY
    Protein Pept Lett; 2012 Apr; 19(4):422-9. PubMed ID: 22185506
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structure-based enhancement of boronic acid-based inhibitors of AmpC beta-lactamase.
    Weston GS; Blázquez J; Baquero F; Shoichet BK
    J Med Chem; 1998 Nov; 41(23):4577-86. PubMed ID: 9804697
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systematic Identification and Classification of β-Lactamases Based on Sequence Similarity Criteria: β-Lactamase Annotation.
    Silveira MC; Azevedo da Silva R; Faria da Mota F; Catanho M; Jardim R; R Guimarães AC; de Miranda AB
    Evol Bioinform Online; 2018; 14():1176934318797351. PubMed ID: 30210232
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recent developments in beta-lactamase research and their implications for the future.
    Bush K
    Rev Infect Dis; 1988; 10(4):681-90. PubMed ID: 3055169
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Accurate prediction of protein structural classes by incorporating predicted secondary structure information into the general form of Chou's pseudo amino acid composition.
    Kong L; Zhang L; Lv J
    J Theor Biol; 2014 Mar; 344():12-8. PubMed ID: 24316044
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beta-lactamase inhibitors: the story so far.
    Pérez-Llarena FJ; Bou G
    Curr Med Chem; 2009; 16(28):3740-65. PubMed ID: 19747143
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure-based classification of class A beta-lactamases, an update.
    Philippon A; Jacquier H; Ruppé E; Labia R
    Curr Res Transl Med; 2019 Nov; 67(4):115-122. PubMed ID: 31155436
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predicting protein fold types by the general form of Chou's pseudo amino acid composition: approached from optimal feature extractions.
    Liu L; Hu XZ; Liu XX; Wang Y; Li SB
    Protein Pept Lett; 2012 Apr; 19(4):439-49. PubMed ID: 22185500
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New promising β-lactamase inhibitors for clinical use.
    Olsen I
    Eur J Clin Microbiol Infect Dis; 2015 Jul; 34(7):1303-8. PubMed ID: 25864193
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of 76 novel B1 metallo-β-lactamases through large-scale screening of genomic and metagenomic data.
    Berglund F; Marathe NP; Österlund T; Bengtsson-Palme J; Kotsakis S; Flach CF; Larsson DGJ; Kristiansson E
    Microbiome; 2017 Oct; 5(1):134. PubMed ID: 29020980
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acquired carbapenem-hydrolyzing beta-lactamases and their genetic support.
    Poirel L; Nordmann P
    Curr Pharm Biotechnol; 2002 Jun; 3(2):117-27. PubMed ID: 12022255
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SHV-type beta-lactamases.
    Tzouvelekis LS; Bonomo RA
    Curr Pharm Des; 1999 Nov; 5(11):847-64. PubMed ID: 10539992
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SPrenylC-PseAAC: A sequence-based model developed via Chou's 5-steps rule and general PseAAC for identifying S-prenylation sites in proteins.
    Hussain W; Khan YD; Rasool N; Khan SA; Chou KC
    J Theor Biol; 2019 May; 468():1-11. PubMed ID: 30768975
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predicting protein structural class by incorporating patterns of over-represented k-mers into the general form of Chou's PseAAC.
    Qin YF; Wang CH; Yu XQ; Zhu J; Liu TG; Zheng XQ
    Protein Pept Lett; 2012 Apr; 19(4):388-97. PubMed ID: 22316305
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insights into class D beta-lactamases are revealed by the crystal structure of the OXA10 enzyme from Pseudomonas aeruginosa.
    Maveyraud L; Golemi D; Kotra LP; Tranier S; Vakulenko S; Mobashery S; Samama JP
    Structure; 2000 Dec; 8(12):1289-98. PubMed ID: 11188693
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of clinically important β-lactamases by using PCR.
    Mlynarcik P; Dolejska M; Vagnerova I; Kutilová I; Kolar M
    FEMS Microbiol Lett; 2021 Jun; 368(11):. PubMed ID: 34100944
    [TBL] [Abstract][Full Text] [Related]  

  • 39. iMem-2LSAAC: A two-level model for discrimination of membrane proteins and their types by extending the notion of SAAC into chou's pseudo amino acid composition.
    Arif M; Hayat M; Jan Z
    J Theor Biol; 2018 Apr; 442():11-21. PubMed ID: 29337263
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incorporating secondary features into the general form of Chou's PseAAC for predicting protein structural class.
    Liao B; Xiang Q; Li D
    Protein Pept Lett; 2012 Nov; 19(11):1133-8. PubMed ID: 22185510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.